Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

Pancreatic cancer (PC) is among the most aggressive types of cancer, having caused over 495,000 deaths worldwide in 2020, with increasing annual incidence. Pancreatic cystic lesions (PCLs) are protrusions found within or on the surface of the pancreas, and in many cases have the potential to become...

Full description

Bibliographic Details
Main Authors: Laura E Kane, Gregory S Mellotte, Kevin C Conlon, Barbara M Ryan, Stephen G Maher
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
pancreatic cancer
pancreatic cystic lesion
biomarker
risk
omics
multi-omics
Online Access:https://www.mdpi.com/2072-6694/13/4/769

Similar Items

Similar Items